We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.9%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$113B
AUM Growth
+$3.29B
(+3%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
17.16%
Holding
4,363
New
403
Increased
1,677
Reduced
1,774
Closed
295
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$603M |
| 2 |
Entergy
ETR
|
+$403M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$296M |
| 5 |
CELG
Celgene Corp
CELG
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.67B |
| 2 |
AABA
Altaba Inc
AABA
|
+$373M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$232M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$229M |
| 5 |
IBM
IBM
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.95% |
| 2 | Healthcare | 10.9% |
| 3 | Financials | 9.6% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Industrials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SDEV
3901
Stablecoin Development Corp
SDEV
$30.6M
| $35K | ﹤0.01% |
+3
| New | +$18.8K |
|
3902
Acacia Research
ACTG
$437M
| $34K | ﹤0.01% |
11,454
-2,358
| -17% | -$7.35K |
|
3903
MediWound
MDWD
$184M
| $34K | ﹤0.01% |
+1,429
| New | +$44.1K |
|
|
TOUR
3904
Tuniu
TOUR
$56.2M
| $34K | ﹤0.01% |
1,053
+8
| +0.8% | +$314 |
|
3905
Neonode
NEON
$12.6M
| $33K | ﹤0.01% |
15,320
+340
| +2% | +$1.08K |
|
|
TLGT
3906
DELISTED
Teligent, Inc
TLGT
| $32K | ﹤0.01% |
+5,110
| New | +$41.7K |
|
|
VSA
3907
VisionSys AI
VSA
$8.3M
| $31K | ﹤0.01% |
5
-8
| -62% | -$81.9K |
|
|
OSG
3908
DELISTED
Overseas Shipholding Group Inc.
OSG
| $31K | ﹤0.01% |
16,817
+4,071
| +32% | +$7.54K |
|
3909
Smart Sand
SND
$179M
| $30K | ﹤0.01% |
12,321
+1,242
| +11% | +$4.4K |
|
|
XNET
3910
Xunlei
XNET
$333M
| $29K | ﹤0.01% |
11,105
-11,592
| -51% | -$35.7K |
|
|
TTOO
3911
DELISTED
T2 Biosystems, Inc
TTOO
| $29K | ﹤0.01% |
+4
| New | +$46.9K |
|
|
ATTO
3912
DELISTED
Atento S.A.
ATTO
| $28K | ﹤0.01% |
2,252
-1,643
| -42% | -$25.8K |
|
|
NIHD
3913
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $28K | ﹤0.01% |
16,283
-45,992
| -74% | -$87.6K |
|
3914
Aqua Metals
AQMS
$9.78M
| $27K | ﹤0.01% |
+80
| New | +$35.2K |
|
|
LITS
3915
Lite Strategy Inc
LITS
$32.4M
| $27K | ﹤0.01% |
+541
| New | +$31.7K |
|
|
MGI
3916
DELISTED
MoneyGram International, Inc. New
MGI
| $27K | ﹤0.01% |
10,732
-8,127
| -43% | -$18.2K |
|
|
TYME
3917
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $27K | ﹤0.01% |
22,333
-1,880
| -8% | -$2.63K |
|
3918
Lineage Cell Therapeutics
LCTX
$264M
| $26K | ﹤0.01% |
23,583
-4,202
| -15% | -$4.84K |
|
|
XELA
3919
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $26K | ﹤0.01% |
1
| – | – |
|
3920
Stagwell
STGW
$2B
| $25K | ﹤0.01% |
10,013
-1,427
| -12% | -$3.67K |
|
|
BFX
3921
DELISTED
BowFlex Inc.
BFX
| $25K | ﹤0.01% |
11,219
-9,344
| -45% | -$36.9K |
|
3922
Verastem
VSTM
$528M
| $24K | ﹤0.01% |
1,370
-107
| -7% | -$2.42K |
|
|
NYMX
3923
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $23K | ﹤0.01% |
+15,765
| New | +$27.6K |
|
|
DRRX
3924
DELISTED
DURECT Corp
DRRX
| $22K | ﹤0.01% |
3,366
-390
| -10% | -$2.43K |
|
3925
Safe Bulkers
SB
$772M
| $18K | ﹤0.01% |
12,017
-107
| -0.9% | -$166 |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2019 Portfolio in Review
As of Q2 2019, Credit Suisse held 4,363 positions worth $113B, up 3% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse's Q2 2019 filing shows 403 new, 1,677 increased, 1,774 reduced and 295 closed positions. Its largest new stake was Alcon: 10,270,934 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.67B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- Credit Suisse's largest Q2 2019 buy was Alcon: 10,270,934 shares worth $637M.
- Credit Suisse added most to Entergy in Q2 2019, an estimated $403M increase.
- Credit Suisse's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.67B.
- Credit Suisse fully exited iShares Core MSCI Total International Stock ETF in Q2 2019, selling an estimated $232M.
- Credit Suisse's ten largest holdings make up 17% of its $113B portfolio in Q2 2019.
- Credit Suisse opened 403 new positions and closed 295 in Q2 2019.
- Credit Suisse's portfolio value rose 3% quarter-over-quarter to $113B.
Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.